6-bromo-1,2,3,4-tetrahydro-1,5-naphthyridine, 95.0%, 2.5g

3,5-Di-tert-butylbenzaldehyde, 95.0%, 25g

1-{4-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidin-1-yl}ethan-1-one, %, 1g

(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 97.0%, 250mg

(E)-N,N-dimethyl-4-(o-tolyldiazenyl)aniline, 98%, 5g

Methyl 3-bromo-2,4-dimethylbenzoate, 95.0%, 100mg

7-Epi 10-desacetyl paclitaxel, 2mg

3,5-Dibromopyridine N-oxide, 97.0%, 5g

2-Bromo-4-fluorobenzoic acid, 97.0%, 10g

Reaction vessel lid, clamp and ring Lid NS 45/40, 29/32, 19/26

1-Bromo-2-chloro-3-fluorobenzene, 98.0%, 500g

6-Methoxy-1H-pyrrolo[2,3-b]pyridine, 95.0%, 250mg

5-Bromo-1,7-naphthyridine-3-carboxylic acid, 98%, 5g